1. Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 2021; 71:209–49
Google Scholar | Crossref | Medline2. de Dios, NR, Murcia-Mejia, M. Current and future strategies in radiotherapy for small-cell lung cancer. J Clin Transl Res 2020; 6:97–108
Google Scholar | Medline3. Arellano, EA, Diaz, VD, Rodriguez, JJC. Current status and future directions in unresectable stage III non-small cell lung cancer. J Clin Transl Res 2020; 6:109–20
Google Scholar | Medline4. Lichota, A, Gwozdzinski, K. Anticancer activity of natural compounds from plant and marine environment. Ijms 2018; 19: 3533
Google Scholar | Crossref5. Fang, D, Xiong, Z, Xu, J, Yin, J, Luo, R. Chemopreventive mechanisms of galangin against hepatocellular carcinoma: a review. Biomed Pharmacother 2019; 109:2054–61
Google Scholar | Crossref | Medline6. Devadoss, D, Ramar, M, Chinnasamy, A. Galangin, a dietary flavonol inhibits tumor initiation during experimental pulmonary tumorigenesis by modulating xenobiotic enzymes and antioxidant status. Arch Pharm Res 2018; 41:265–75
Google Scholar | Crossref | Medline7. Liu, D, You, P, Luo, Y, Yang, M, Liu, Y. Galangin induces apoptosis in MCF-7 human breast cancer cells through mitochondrial pathway and phosphatidylinositol 3-Kinase/akt inhibition. Pharmacology 2018; 102:58–66
Google Scholar | Crossref | Medline8. Huang, H, Chen, AY, Ye, X, Guan, R, Rankin, GO, Chen, YC. Galangin, a flavonoid from lesser galangal, induced apoptosis via p53-dependent pathway in ovarian cancer cells. Molecules 2020; 25:1579
Google Scholar | Crossref9. Liang, X, Wang, P, Yang, C, Huang, F, Wu, H, Shi, H, Wu, X. Galangin inhibits gastric cancer growth through enhancing STAT3 mediated ROS production. Front Pharmacol 2021; 12:646628
Google Scholar | Crossref | Medline10. Ha, TK, Kim, ME, Yoon, JH, Bae, SJ, Yeom, J, Lee, JS. Galangin induces human colon cancer cell death via the mitochondrial dysfunction and caspase-dependent pathway. Exp Biol Med (Maywood) 2013; 238:1047–54
Google Scholar | SAGE Journals | ISI11. Zhong, X, Huang, S, Liu, D, Jiang, Z, Jin, Q, Li, C, Da, L, Yao, Q, Wang, D. Galangin promotes cell apoptosis through suppression of H19 expression in hepatocellular carcinoma cells. Cancer Med 2020; 9:5546–57
Google Scholar | Crossref | Medline12. Xiong, Y, Lai, X, Xiang, W, Zhou, J, Han, J, Li, H, Deng, H, Liu, L, Peng, J, Chen, L. Galangin (GLN) suppresses proliferation, migration, and invasion of human glioblastoma cells by targeting Skp2-induced epithelial-mesenchymal transition (EMT). Onco Targets Ther 2020; 13:9235–44
Google Scholar | Crossref | Medline13. Kong, Y, Feng, Z, Chen, A, Qi, Q, Han, M, Wang, S, Zhang, Y, Zhang, X, Yang, N, Wang, J, Huang, B, Zhang, Q, Xiang, G, Li, W, Zhang, D, Wang, J, Li, X. The natural flavonoid galangin elicits apoptosis, pyroptosis, and autophagy in glioblastoma. Front Oncol 2019; 9:942
Google Scholar | Crossref | Medline14. Yang, Z, Li, X, Han, W, Lu, X, Jin, S, Yang, W, Li, J, He, W, Qian, Y. Galangin suppresses human osteosarcoma cells: an exploration of its underlying mechanism. Oncol Rep 2017; 37:435–41
Google Scholar | Crossref | Medline15. Chen, D, Li, D, Xu, XB, Qiu, S, Luo, S, Qiu, E, Rong, Z, Zhang, J, Zheng, D. Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma. J Cancer 2019; 10:4499–508
Google Scholar | Crossref | Medline16. Yu, S, Gong, LS, Li, NF, Pan, YF, Zhang, L. Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-kappaB and bcl-2/bax signaling pathways. Biomed Pharmacother 2018; 97:213–24
Google Scholar | Crossref | Medline17. Tolomeo, M, Grimaudo, S, Di Cristina, A, Pipitone, RM, Dusonchet, L, Meli, M, Crosta, L, Gebbia, N, Invidiata, FP, Titone, L, Simoni, D. Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells. Cancer Lett 2008; 265:289–97
Google Scholar | Crossref | Medline18. Huang, YC, Tsai, MS, Hsieh, PC, Shih, JH, Wang, TS, Wang, YC, Lin, TH, Wang, SH. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling. Toxicol Appl Pharmacol 2017; 329:128–39
Google Scholar | Crossref | Medline19. Liu, R, Li, H, Wei, N, Tan, Y. Simultaneous determination of two galangin metabolites from alpinia officinarum hance in rat plasma by UF LC-MS/MS and its application in pharmacokinetics study. PeerJ 2021; 9:e11041
Google Scholar | Crossref | Medline20. Li, Y, Guo, M, Lin, Z, Zhao, M, Xia, Y, Wang, C, Xu, T, Zhu, B. Multifunctional selenium nanoparticles with galangin-induced HepG2 cell apoptosis through p38 and AKT signalling pathway. R Soc Open Sci 2018; 5:180509
Google Scholar | Crossref | Medline21. Otake, Y, Walle, T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metab Dispos 2002; 30:103–5
Google Scholar | Crossref | Medline22. Otake, Y, Hsieh, F, Walle, T. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos 2002; 30:576–81
Google Scholar | Crossref | Medline23. Mak, K-K, Tan, J-J, Marappan, P, Balijepalli, MK, Choudhury, H, Ramamurthy, S, Pichika, MR. Galangin’s potential as a functional food ingredient. Journal of Functional Foods 2018; 46:490–503
Google Scholar | Crossref24. Ma, YL, Zhao, F, Yin, JT, Liang, CJ, Niu, XL, Qiu, ZH, Zhang, LT. Two approaches for evaluating the effects of galangin on the activities and mRNA expression of seven CYP450. Molecules 2019; 24:1171
Google Scholar | Crossref25. Bloor, SJ, Mitchell, KA. Metabolic products of european-type propolis. Synthesis and analysis of glucuronides and sulfates. J Ethnopharmacol 2021; 274:114035
Google Scholar | Crossref | Medline26. Benković, G, Bojic, M, Males, Z, Tomic, S. Screening of flavonoid aglycons' metabolism mediated by the human liver cytochromes P450. Acta Pharmaceut 2019; 69:541–62
Google Scholar | Crossref | Medline27. Chen, F, Tan, YF, Li, HL, Qin, ZM, Cai, HD, Lai, WY, Zhang, XP, Li, YH, Guan, WW, Li, YB, Zhang, JQ. Differential systemic exposure to galangin after oral and intravenous administration to rats. Chem Cent J 2015; 9:14
Google Scholar | Crossref | Medline28. Curti, V, Zaccaria, V, Tsetegho Sokeng, AJ, Dacrema, M, Masiello, I, Mascaro, A, D'Antona, G, Daglia, M. Bioavailability and in vivo antioxidant activity of a standardized polyphenol mixture extracted from brown propolis. Ijms 2019; 20:1250
Google Scholar | Crossref29. Su, L, Chen, X, Wu, J, Lin, B, Zhang, H, Lan, L, Luo, H. Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress. Food and chemical toxicology: an international journal published for the. Food Chem Toxicol 2013; 62:810–6
Google Scholar | Crossref | Medline30. Zhang, H, Li, N, Wu, J, Su, L, Chen, X, Lin, B, Luo, H. Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner. Eur J Pharmacol 2013; 718:235–44
Google Scholar | Crossref | Medline31. Jung, YC, Kim, ME, Yoon, JH, Park, PR, Youn, HY, Lee, HW, Lee, JS. Anti-inflammatory effects of galangin on lipopolysaccharide-activated macrophages via ERK and NF-kappaB pathway regulation. Immunopharmacol Immunotoxicol 2014; 36:426–32
Google Scholar | Crossref | Medline32. Kim, HH, Bae, Y, Kim, SH. Galangin attenuates mast cell-mediated allergic inflammation. Food and chemical toxicology: an international journal published for the british industrial. Food Chem Toxicol 2013; 57:209–16
Google Scholar | Crossref | Medline | ISI33. Jung, CH, Jang, SJ, Ahn, J, Gwon, SY, Jeon, TI, Kim, TW, Ha, TY. Alpinia officinarum inhibits adipocyte differentiation and high-fat diet-induced obesity in mice through regulation of adipogenesis and lipogenesis. J Med Food 2012; 15:959–67
Google Scholar | Crossref | Medline34. Kumar, S, Alagawadi, KR. Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats. Pharm Biol 2013; 51:607–13
Google Scholar | Crossref | Medline35. Choi, JK, Kim, SH. Inhibitory effect of galangin on atopic dermatitis-like skin lesions. Food and chemical toxicology: an international journal published for the British industrial. Food Chem Toxicol 2014; 68:135–41
Google Scholar | Crossref | Medline36. Shu, YS, Tao, W, Miao, QB, Lu, SC, Zhu, YB. Galangin dampens mice lipopolysaccharide-induced acute lung injury. Inflammation 2014; 37:1661–8
Google Scholar | Crossref | Medline37. Kazemi, S, Asadi, F, Barari, L, Morakabati, P, Jahani, M, Kani, SNM, Soorani, F, Kolangi, F, Memariani, Z. Quantification of flavonoids in alpinia officinarum hance. via HPLC and evaluation of its cytotoxicity on human prostate carcinoma (LNCaP) and breast carcinoma (MCF-7) cells. Acamc 2021;doi: 10.2174/1871520621666210706142157. In press.
Google Scholar | Crossref38. Kumar, R, Tiku, AB. Galangin induces cell death by modulating the expression of glyoxalase-1 and nrf-2 in HeLa cells. Chem Biol Interact 2018; 279:1–9
Google Scholar | Crossref | Medline39. Zou, WW, Xu, SP. Galangin inhibits the cell progression and induces cell apoptosis through activating PTEN and caspase-3 pathways in retinoblastoma. Biomed Pharmacother 2018; 97:851–63
Google Scholar | Crossref | Medline40. Zou Y, Li R, Kuang D, Zuo M, Li W, Tong W, Jiang L, Zhou M, Chen Y, Gong W, Liu L, Tou F. Galangin inhibits cholangiocarcinoma cell growth and metastasis through downregulation of MicroRNA-21 expression. BioMed Res Int 2020;2020:5846938
Google Scholar41. Zhu, Y, Rao, Q, Zhang, X, Zhou, X. Galangin induced antitumor effects in human kidney tumor cells mediated via mitochondrial mediated apoptosis, inhibition of cell migration and invasion and targeting PI3K/AKT/mTOR signalling pathway. Journal of BUON: official Journal of the Balkan Union of Oncology 2018; 23:795–9
Google Scholar | Medline42. Wang, HX, Tang, C. Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways. Oncol Rep 2017; 38:703–14
Google Scholar | Crossref | Medline43. Song, W, Yan, CY, Zhou, QQ, Zhen, LL. Galangin potentiates human breast cancer to apoptosis induced by TRAIL through activating AMPK. Biomed Pharmacother 2017; 89:845–56
Google Scholar | Crossref | Medline44. Han, MA, Lee, DH, Woo, SM, Seo, BR, Min, KJ, Kim, S, Park, JW, Kim, SH, Choi, YH, Kwon, TK. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma caki cells. Sci Rep 2016; 6:18642
Google Scholar | Crossref | Medline45. Lee, CC, Lin, ML, Meng, M, Chen, SS. Galangin induces p53-independent S-phase arrest and apoptosis in human nasopharyngeal carcinoma cells through inhibiting PI3K-AKT signaling pathway. Anticancer Res 2018; 38:1377–89
Google Scholar | Medline46. Zhu, L, Luo, Q, Bi, J, Ding, J, Ge, S, Chen, F. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo. Chem Biol Interact 2014; 224:149–56
Google Scholar | Crossref | Medline47. Murray, TJ, Yang, X, Sherr, DH. Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res 2006; 8:R17
Google Scholar | Crossref | Medline48. Kashyap, D, Garg, VK, Tuli, HS, Yerer, MB, Sak, K, Sharma, AK, Kumar, M, Aggarwal, V, Sandhu, SS. Fisetin and quercetin: promising flavonoids with chemopreventive potential. Biomolecules 2019; 9:174
Google Scholar | Crossref49. Kashyap, D, Sharma, A, Tuli, HS, Sak, K, Mukherjee, T, Bishayee, A. Molecular targets of celastrol in cancer: recent trends and advancements. Crit Rev Oncol Hematol 2018; 128:70–81
Google Scholar |